GlaxoSmithKline has agreed to splash out $13bn (£9.1bn) in cash to buy a 36.5 per cent stake currently owned by Swiss pharmaceuticals giant Novartis in a consumer healthcare joint venture between the two companies, and has said that it will launch a … Powered by WPeMatico
The post GSK to buy stake in Novartis consumer healthcare join venture for $13bn and considers selling Horlicks appeared first on Dr. Kianor Shah - Professional Speaker, Dentist, Implant Surgeon, Fintech Expert, Entrepreneur.